top of page
All Posts
The Tsunami of "Wait and See": How Radiomics Can Save the Nurse Navigator
In the world of lung nodule management, the Nurse Navigator is the engine room. Every day, a "tsunami" of incidental findings—roughly 14,000 daily across the U.S. —hits hospital worklists. For the navigator, this creates a crushing paradox: The Volume Trap: 75% of these nodules are under 8mm. To the human eye, they look virtually identical. The "Wait and See" Anxiety: Because we can’t visually distinguish risk at this size, we follow the "standard" protocol: tell the patien
Ryan Brevard
Apr 12 min read
RevealDX obtains FDA Clearance
February 3, 2026 Seattle, WA – February 3, 2026 – RevealDx, a leader in AI tools for the characterization of lung nodules,announced FDA clearance of RevealAI-Lung. The company had previously announced MDR Certification inNovember of 2025. The RevealDx technology characterizes incidental lung nodules by producing a Malignancy Similarity Index(mSI™), a score that is intended to help radiologists make more informed follow-up recommendations to assist in cancer diagnosis. The com
Ryan Brevard
Feb 32 min read
The Power of Incidental Lung Nodules
Don't let a lung nodule go unnoticed Incidental findings on CT scans offer a powerful opportunity. While concerns about radiation...
Ryan Brevard
Jun 18, 20251 min read
The Looming Nodule Crisis- Radiomics to the rescue
The nodules just keep piling up..... Each year, millions of lung nodules are detected, yet only a small fraction (5%) are malignant,...
Mat Brevard
Jun 9, 20251 min read
bottom of page